Abcam Plc - Company Profile
Powered by
All the data and insights you need on Abcam Plc in one report.
- Save hours of research time and resources with
our up-to-date Abcam Plc Strategy Report
- Understand Abcam Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Abcam Plc (Abcam) is a biotechnology company that focuses on the research, development, marketing and sales of research-grade antibodies and related products. Its product portfolio comprises antibody reagents, antigens and test-kits. Strong presence in antibodies and reagents market, strong operational performance and proprietary RabMab technology are its strengths, while reliance on distributors could be an area for concern for the company. Abcam could benefit from growing need for COVID-19 diagnostics, and strategic agreements. However, its performance could be affected by stiff competition, introduction of innovative technologies and stringent government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer